Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Prinses Máxima Centrum Voorpagina
Nederlands
English
Content zoeken bij Prinses Máxima Centrum
Voorpagina
Profielen
Onderzoeksgroepen
Uitrusting
Onderzoeksoutput
Prijzen
Activiteiten
Knipsels
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients
Simone De Vries
, Michael Schaapveld
, Cécile P.M. Janus
, Laurien A. Daniëls
, Eefke J. Petersen
, Richard W.M. Van Der Maazen
, Josée M. Zijlstra
, Max Beijert
, Marten R. Nijziel
, Karijn M.S. Verschueren
,
Leontien C.M. Kremer
, Anna M. Van Eggermond
, Pieternella J. Lugtenburg
, Augustinus D.G. Krol
, Judith M. Roesink
, Wouter J. Plattel
, Dick Johan Van Spronsen
, Gustaaf W. Van Imhoff
, Jan Paul De Boer
, Berthe M.P. Aleman
Flora E. Van Leeuwen
Toon overzicht 1 andere
Toon minder
Group Kremer
Onderzoeksoutput
:
Bijdrage aan tijdschrift
›
Artikel
›
peer review
81
Citaten (Scopus)
Overzicht
Vingerafdruk
Vingerafdruk
Duik in de onderzoeksthema's van 'Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients'. Samen vormen ze een unieke vingerafdruk.
Sorteer per
Gewicht
Alfabetische volgorde
Keyphrases
Lymphoma Patients
100%
Hodgkin Lymphoma
100%
Cause-specific Mortality
100%
Confidence Interval
60%
Chemotherapy
40%
Excess Mortality
40%
Radiotherapy
30%
Cumulative Mortality
20%
Standardized Mortality Ratio
20%
Hodgkin Lymphoma Survivors
20%
Solid Tumors
10%
Patient Selection
10%
High Risk
10%
Survivors
10%
Hazard Ratio
10%
Spleen
10%
Life Expectancy
10%
Irradiation
10%
Older Individuals
10%
Cause-specific
10%
Long-term Toxicity
10%
Treatment-related Morbidity
10%
Risk of Death
10%
Competing Risks
10%
By Stages
10%
Radiotherapy Alone
10%
Chemotherapy Alone
10%
Multicenter Cohort
10%
Treatment Impact
10%
Primary Chemotherapy
10%
Infection-related Mortality
10%
Optimal Selection
10%
Splenectomy
10%
Lymphoma Relapse
10%
Calendar Period
10%
Cardiovascular Mortality
10%
Subdistribution Hazard Ratio
10%
Immunology and Microbiology
Mortality
100%
Population
66%
Standardized Mortality Ratio
66%
Infectious Disease
33%
Life Expectancy
33%
Medicine and Dentistry
Hodgkin's Lymphoma
100%
Chemotherapy
50%
Radiation Therapy
33%
Mortality
25%
Hazard Ratio
16%
Population
16%
Standardized Mortality Ratio
16%
Solid Malignant Neoplasm
8%
Infection
8%
Life Expectancy
8%
Cardiovascular Disease
8%
Splenectomy
8%
Nursing and Health Professions
Hodgkin Disease
100%
Confidence Interval
50%
Radiotherapy
33%
Mortality
25%
Population
16%
Hazard Ratio
16%
Standardized Mortality Ratio
16%
Infection
8%
Solid Malignant Neoplasm
8%
Cardiovascular Disease
8%
Splenectomy
8%
Life Expectancy
8%
Pharmacology, Toxicology and Pharmaceutical Science
Hodgkin Disease
100%
Chemotherapy
50%
Mortality
25%
Standardized Mortality Ratio
16%
Solid Malignant Neoplasm
8%
Infection
8%
Life Expectancy
8%
Cardiovascular Disease
8%
Psychology
Infectious Disease
50%